TY - JOUR
T1 - Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line
AU - Jaffe, Eric A.
AU - Armellino, Douglas
AU - Tollefsen, Douglas M.
N1 - Funding Information:
We thank George Lam for expert technical supported by grants from the National Institutes 27589) and the Arnold R. Krakower Hematology recipient of a National Institutes of Health (HL-01079).
PY - 1985/10/15
Y1 - 1985/10/15
N2 - Human plasma heparin cofactor II (HCII) inhibits thrombin by rapidly forming a stable, equimolar complex in the presence of heparin or dermatan sulfate. Cultured human hepatoma-derived cells ( PLC PRF-5) secreted (≈200 ng/ml in 3 days) a protein of MW - 72 kD that was immunoisolated and immunoblotted with anti-HCII, co-migrated on SDS-PAGE with human plasma HCII, and formed covalent complexes with thrombin (MW - 101 kD) in the presence but not absence of heparin or dermatan sulfate; these complexes co-migrated with those obtained by incubating thrombin with human plasma under the same conditions. HCII was not detectable (< 0.13 ng/ml) in post-culture medium from cultured human umbilical vein endothelial cells or human foreskin fibroblasts.
AB - Human plasma heparin cofactor II (HCII) inhibits thrombin by rapidly forming a stable, equimolar complex in the presence of heparin or dermatan sulfate. Cultured human hepatoma-derived cells ( PLC PRF-5) secreted (≈200 ng/ml in 3 days) a protein of MW - 72 kD that was immunoisolated and immunoblotted with anti-HCII, co-migrated on SDS-PAGE with human plasma HCII, and formed covalent complexes with thrombin (MW - 101 kD) in the presence but not absence of heparin or dermatan sulfate; these complexes co-migrated with those obtained by incubating thrombin with human plasma under the same conditions. HCII was not detectable (< 0.13 ng/ml) in post-culture medium from cultured human umbilical vein endothelial cells or human foreskin fibroblasts.
UR - http://www.scopus.com/inward/record.url?scp=0022389139&partnerID=8YFLogxK
U2 - 10.1016/0006-291X(85)91031-9
DO - 10.1016/0006-291X(85)91031-9
M3 - Article
C2 - 2998359
AN - SCOPUS:0022389139
SN - 0006-291X
VL - 132
SP - 368
EP - 374
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -